COVID-19

Ha Won Song1, Hye-Yeong Jo2, Sang Cheol Kim2

  • 1Division of Biomedical Convergence, College of Biomedical Science, Institute of Bioscience & Biotechnology, Kangwon National University, Chuncheon, 24341, Korea.

BMC infectious diseases
|November 4, 2024
PubMed
概括

两个蛋白质因子,Serpin A10和补充C9,区分COVID-19的严重程度. 症状患者表现出免疫细胞水平的改变,影响免疫病理学和潜在的治疗方法.